A labelling system improves parental comfort and willingness to use topical corticosteroids for paediatric atopic dermatitis

OBJECTIVES: In the United Kingdom, atopic dermatitis (AD) affects 20% of children and topical corticosteroids (TCS) are a mainstay of AD treatment regimes. Many TCS have similar packaging despite significant differences in potency frequently leading to confusion, and along with misinformation and st...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, F., Harnik, E., Gore, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060095/
https://www.ncbi.nlm.nih.gov/pubmed/35664821
http://dx.doi.org/10.1002/ski2.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060095/
https://www.ncbi.nlm.nih.gov/pubmed/35664821
http://dx.doi.org/10.1002/ski2.11

Ejemplares similares